CHENNAI, INDIA, February 14, 2013 (Press-News.org) Polaris Financial Technology Ltd, a leader in products, solutions and services that enable unprecedented operational productivity for the global Financial Services industry, today signed a definitive agreement with US based Numerix, a leading provider of cross-asset analytics for derivatives valuations and risk management. Leveraging Numerix's newly introduced analytics calculation engine, CrossAsset Server and CrossAsset Integration Layer for the integration, this partnership will provide clients with Numerix risk analytics for improved risk monitoring, increased transparency and decision making.
Polaris' Intellect Risk and Treasury has more than 40 customers across 80 countries, which will now be able to comply with Basel regulatory requirements, such as consistent pricing, stress testing and accurate reporting of Credit Valuation Adjustment for robust Counterparty Credit Risk management, by leveraging Numerix's comprehensive model library and risk analytics embedded as part of the solution. In addition, Polaris will support banks to integrate Numerix models into their end-to-end pricing and risk management solutions.
Speaking on the occasion, Mr. Manish Maakan, Partner & Global Head - Intellect Business, Polaris Financial Technology Limited said, "Regulatory pressure and changing business needs demand that banks, both buy side and sell side, be able to access trading and risk management information across assets with reliable risk models. Banks therefore need customizable solutions to comply with regulatory Basel requirements. We now empower banks to seamlessly comply with regulatory and Basel compliance at a competitive price point with Polaris' Treasury/Risk IP and Numerix's risk analytics."
Steven R. O'Hanlon, Chief Executive Officer & President, Numerix said, "Numerix has a proven track record of providing users with market leading risk management and pricing analytics software to structure and value any conceivable type of financial instrument -- from vanillas to the most complex deals. We needed a partner with scale and reach who can provide access to various global markets and we are excited about the opportunity to partner with a global financial technology leader like Polaris."
As the global leader in cross-asset analytics for vanillas through to the most exotic Over-the-Counter (OTC) and structured products, Numerix provides support for pre-trade pricing, structuring, trade capture, valuation, market risk (all Value at Risk measures) and counterparty risk calculations including Credit Valuation Adjustment (CVA), Debit Valuation Adjustment(DVA), Potential Future Exposure(PFE) and Funding Value Adjustment(FVA). Numerix provides comprehensive coverage for all major asset classes, including fixed income, inflation, credit, equity, foreign exchange and commodity instruments, as well as hybrids.
With a flexible and transparent framework and the industry's most sophisticated library of pricing and risk models at its core, the Numerix analytics platform is the market standard for cross-asset analytics. Many of the top trading and risk platforms used by today's financial institutions and corporate treasuries have embedded the Numerix model library and pricing architecture inside their systems. This offers a consistent pricing framework that spans a wide range of standard technology platforms, fostering transparency throughout the derivatives market.
About Numerix
Numerix is the award winning, leading independent analytics institution providing cross-asset solutions for structuring, pre-trade price discovery, trade capture, valuation and portfolio management of derivatives and structured products. Since its inception in 1996, over 700 clients and 75 partners across more than 25 countries have come to rely on Numerix analytics for speed and accuracy in valuing and managing the most sophisticated financial instruments. With offices in New York, London, Paris, Frankfurt, Milan, Stockholm, Tokyo, Hong Kong, Singapore, Dubai, South Korea, India and Australia, Numerix brings together unparalleled expertise across all asset classes and engineering disciplines. For more information please visit www.numerix.com.
About Polaris Financial Technology Ltd
Polaris Financial Technology Ltd (formerly known as Polaris Software Lab Ltd) (POLS.BO) is a leader in Products, Solutions and Services that enable unprecedented operational productivity for the global Financial Services industry with its comprehensive portfolio of products and services. Polaris has a talent strength of over 13,000 solution architects, domain and technology experts. The company owns the largest set of Intellectual Properties for a comprehensive product suite, Intellect Global Universal Banking (GUB) M180. Intellect is the first pure play Service Oriented Architecture (SOA) based application suite for Retail, Corporate, Investment banking and Insurance.
Headquartered in Chennai, Polaris has offices in all global financial hubs, including Bangalore, Belfast, Chennai, Chicago, Dhaka, Dublin, Dubai, Frankfurt, Hong Kong, Ho Chi Minh City, Hyderabad, Kuala Lumpur, Lisle, London, Madrid, Manila, Melbourne, Mississauga, Mumbai, Nairobi , Neuchatel, New Delhi, New York (New Jersey), Paris, Pittsburgh, Pune, Riyadh, Santiago, San Francisco, Seoul, Shanghai, Singapore, St. Germain En Laye, Sydney, Thane, Tokyo, Toronto, Victoria and Wicklow. For more information, please visit http://www.polarisFT.com/
For Media related info, please contact:
Minal Sahani
Polaris Financial Technology Ltd
Mob: +91 91766 26468
Email: minal.sahani@polarisFT.com
For Investor related info, please contact:
G. Sunanthy Devi
Polaris Financial Technology Ltd
Mob: +91 8939933564
Email: sunanthy.g@polarisFT.com
For Numerix related info, please contact:
Emily Ahearn
Numerix
Office: 646-898-1294
Email: eahearn@numerix.com
Polaris FT Partners with Numerix for Credit Valuation Adjustment and Advanced Risk Capabilities
Polaris FT signed a definitive agreement with US based Numerix, a leading provider of cross-asset analytics for derivatives valuations and risk management.
2013-02-14
ELSE PRESS RELEASES FROM THIS DATE:
NightPod Images Bring Earth to Light From Space Station
2013-02-14
There is a reason the phrase "shooting in the dark" refers to things that are difficult to do -- and night photography is no exception. To account for low-light image scenarios, a photographer needs a steady tripod, but aboard the International Space Station, a traditional tripod isn't going to cut it. Thankfully, the European Space Agency, or ESA, developed NightPod for the crew's cameras.
This astronaut photograph of Liege, Belgium, at night was taken using the NightPod camera mount aboard the space station. The mechanism allows astronauts to capture images ...
The Container Store to Share Thousands of Hugs in Honor of "National We Love Our Employees Day"
2013-02-14
The Container Store (R), the nation's originator and leading retailer of storage and organization products, today honors its 6,000 employees across the country by celebrating its fourth annual "National We Love Our Employees Day (TM)." In 2010, the company proclaimed February 14 as its National We Love Our Employees Day to not only celebrate its own employee-first culture, but to also encourage other companies to do so.
Today's companywide celebration includes special "warm" surprises for every employee from Long Island to Los Angeles and even the ...
NE-WHERE Electronic Cigarettes Now Available at 7-Eleven Stores
2013-02-14
According to a spokesperson for NE-WHERE, the company's popular selling brand of electronic cigarettes are now available for purchase at local participating 7-Eleven stores. The well-established convenience store chain long known for its Big Gulp, will now also offer smokers this increasingly attractive alternative to traditional "tobacco" cigarettes.
This is definitely a coup for the high quality electronic cigarette maker with innovative packaging, which is now being sold at gas stations and drugstores across the western United States. All three popular flavors ...
Platelet-rich plasma treatment shows potential for knee osteoarthritis
2013-02-13
A study by researchers from Hospital for Special Surgery has shown that platelet-rich plasma (PRP) holds great promise for treating patients with knee osteoarthritis. The treatment improved pain and function, and in up to 73% of patients, appeared to delay the progression of osteoarthritis, which is a progressive disease. The study appears online, ahead of print, in the Clinical Journal of Sports Medicine.
"This is a very positive study," said Brian Halpern, M.D., chief of the Primary Care Sports Medicine Service at Hospital for Special Surgery, New York City, and lead ...
Detecting cocaine 'naturally'
2013-02-13
This press release is available in French.
Montréal, February 13, 2013 – Since the beginning of time, living organisms have developed ingenious mechanisms to monitor their environment. As part of an international study, a team of researchers has adapted some of these natural mechanisms to detect specific molecules such as cocaine more accurately and quickly. Their work may greatly facilitate the rapid screening—less than five minutes—of many drugs, infectious diseases, and cancers.
Professor Alexis Vallée-Bélisle of the University of Montreal Department of Chemistry ...
UTHealth: Alcohol consumption may be in response to smoking cessation
2013-02-13
HOUSTON – (Feb.12, 2013) – New findings by researchers at The University of Texas Health Science Center at Houston (UTHealth) School of Public Health may help identify situations in which smokers who are trying to quit are at a higher risk of relapse.
More than 1,200 people die in the United States every day from smoking-related illnesses. This is equivalent to three airplanes loaded with passengers crashing everyday in America. Smoking-related illnesses are the No. 1 cause of preventable deaths in the country, killing more Americans than drugs, homicides, suicides, ...
UCSB study of cocaine addiction reveals targets for treatment
2013-02-13
(Santa Barbara, Calif.) –– Scientists at UC Santa Barbara are researching cocaine addiction, part of a widespread problem, which, along with other addictions, costs billions of dollars in damage to individuals, families, and society. Laboratory studies at UCSB have revealed that the diminished brain function and learning impairment that result from cocaine addiction can be treated –– and that learning can be restored.
Karen Szumlinski, a professor in the Department of Psychological & Brain Sciences at UCSB, and her colleagues Osnat Ben-Shahar and Tod Kippin, have worked ...
Emerging cancer drugs may drive bone tumors
2013-02-13
Cancer drugs should kill tumors, not encourage their spread. But new evidence suggests that an otherwise promising class of drugs may actually increase the risk of tumors spreading to bone, according to researchers at Washington University School of Medicine in St. Louis.
The drugs, IAP antagonists, block survival signals that many cancer cells rely on to stay alive. Working in mice, the investigators found that targeting the same protein that makes tumors vulnerable to death also overactivates cells called osteoclasts, which are responsible for tearing down bone.
"These ...
Flu outbreaks modeled by new study of classroom schedules
2013-02-13
Classroom rosters combined with human-networking theory may give a clearer picture of just how infectious diseases such as influenza can spread through a closed group of people, and even through populations at large. Using high-school schedule data for a community of students, teachers, and staff, Penn State University's Marcel Salathé, an assistant professor of biology, and Timo Smieszek, a post-doctoral researcher, have developed a low-cost but effective method to determine how to focus disease-control strategies based on which individuals are most likely to spread the ...
Does race make a difference in monitoring of opioid pain therapy?
2013-02-13
Philadelphia, PA, February 12, 2013 – Opioids are frequently prescribed for pain management in noncancer patients, but recommended clinical guidelines for monitoring effectiveness and signs of drug abuse are often not implemented. Alongside well-documented racial disparities in prescribing opioid medications for pain, researchers report racial differences in the use of recommended opioid monitoring and follow-up treatment practices. The study is published in the current issue of PAIN®.
"In our study, we examined whether racial disparities exist in a more comprehensive ...
LAST 30 PRESS RELEASES:
Low-dose ketamine shows promise for pain relief in emergency department patients
Lifestyle & risk factor changes improved AFib symptoms, not burden, over standard care
Researchers discover new cognitive blueprint for making and breaking habits
In a small international trial, novel oral medication muvalaplin lowered Lp(a)
Eradivir’s EV25 therapeutic proven to reduce advanced-stage influenza viral loads faster, more thoroughly in preclinical studies than current therapies
Most Medicare beneficiaries do not compare prescription drug plans – and may be sticking with bad plans
“What Would They Say?” video wins second place in international award for tobacco control advocacy
Black Britons from top backgrounds up to three times more likely to be downwardly mobile
Developing an antibody to combat age-related muscle atrophy
Brain aging and Alzheimer's: Insights from non-human primates
Can cells ‘learn’ like brains?
How cells get used to the familiar
Seemingly “broken” genes in coronaviruses may be essential for viral survival
Improving hurricane modeling with physics-informed machine learning
Seed slippage: Champati cha-cha
Hospitalization following outpatient diagnosis of RSV in adults
Beyond backlash: how feeling threatened by diversity can trigger positive change
Climate change exposure associated with increased emergency imaging
Incorrect AI advice influences diagnostic decisions
Building roots in glass, a bio-inspired approach to creating 3D microvascular networks using plants and fungi
Spinning fusion fuel for efficiency
The American Pediatric Society names Dr. Beth Tarini as the recipient of the 2025 Norman J. Siegel New Member Outstanding Science Award
New Clinical Study Confirms the Anti-Obesity Effects of Kimchi
Highly selective pathway for propyne semihydrogenation achieved via CoSb intermetallic catalyst
GERD linked to cardiovascular risk factors: New insights from Mendelian randomization study
Content moderators are influenced by online misinformation
Adulting, nerdiness and the importance of single-panel comics
Study helps explain how children learned for 99% of human history
The impact of misinformation on Spanish-language social media platforms
Populations overheat as major cities fail canopy goals: new research
[Press-News.org] Polaris FT Partners with Numerix for Credit Valuation Adjustment and Advanced Risk CapabilitiesPolaris FT signed a definitive agreement with US based Numerix, a leading provider of cross-asset analytics for derivatives valuations and risk management.